Trial Size (N) from Pre-Trial Power Calculations | Patients | |
Number of Med-ic Packages per Patient | Packages | |
Estimated Cost to Process one Patient
Estimated Per-Patient Clinical Trial Costs by Phase, 2013
Phase I $38,500. Phase II $40,000. Phase III $42,000. Phase IV $16,500. PhRMA/Battelle. Biopharmaceutical Industry-Sponsored Clinical Trials: Impact on State Economies, March 2015.
|
USD | |
Estimated Time to Enrol N Patients
First patient, first visit to last patient, first visit.
|
Weeks | |
Estimated Percentage Adherence Increase Due to Med-ic
Conservatively estimated improvement in adherence will vary from 5 to 15 percent according to the patient population and the study format.
|
Percent | |
Estimated revenue per additional week on patent | x million USD | |
|
Med-ic reduced N (from |
|
Direct savings from reduced N
Direct savings are due to the reduced cost of processing the smaller sample size required when monitoring and coaching adherence.
|
|
Additional weeks of patent protection |
|
TOTAL ROI |
|